Skip to content
← Back to this collection

PUBLICATIONS · 15542805

Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2004 Nov 15
First author
Hudson MM

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Hudson MM
      type
      Author
    2. name
      Krasin M
      type
      Author
    3. name
      Link MP
      type
      Author
    4. name
      Donaldson SS
      type
      Author
    5. name
      Billups C
      type
      Author
    6. name
      Merchant TE
      type
      Author
    7. name
      Kun L
      type
      Author
    8. name
      Billet AL
      type
      Author
    9. name
      Kaste S
      type
      Author
    10. name
      Tarbell NJ
      type
      Author
    11. name
      Howard S
      type
      Author
    12. name
      Friedmann AM
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Hudson MM
      type
      Author
    2. name
      Krasin M
      type
      Author
    3. name
      Link MP
      type
      Author
    4. name
      Donaldson SS
      type
      Author
    5. name
      Billups C
      type
      Author
    6. name
      Merchant TE
      type
      Author
    7. name
      Kun L
      type
      Author
    8. name
      Billet AL
      type
      Author
    9. name
      Kaste S
      type
      Author
    10. name
      Tarbell NJ
      type
      Author
    11. name
      Howard S
      type
      Author
    12. name
      Friedmann AM
      type
      Author
    bibliography ids
    1. nci-bib-182e01f511cdf9eb3e7932f2
    book metadata
    content sha256
    4891e041e46b65f4cefd9a079097806209e8dd626ad01bc2d0cbdb1ad1c19542
    document type
    citation
    dois
    1. 10.1200/JCO.2004.02.139
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:15542805
    immutable id
    pubmed:15542805@4891e041e46b65f4cefd9a079097806209e8dd626ad01bc2d0cbdb1ad1c19542
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    Source null
    issn print
    0732-183X
    issue
    22
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    4541-50
    volume
    22
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      15542805
      provenance
      batch id
      97b9e848a139d5f8d462
      provider
      NCBI PubMed ESummary
      record sha256
      64c8529e6d3b0dbdfd0d84c3c8e1a0f14f2f6fcb4f382afe9737ebc8bae427d0
      response sha256
      a316b1e9f1b120fc4a41adaaf2b205cc00afcf76d9a093a7cfa9ed2743d05be8
      retrieved at
      2026-09-09T23:45:57.930512+00:00
      publication date
      display
      2004 Nov 15
      precision
      day
      year
      2004
      publication types
      1. Clinical Trial
      2. Journal Article
      3. Multicenter Study
      4. Research Support, Non-U.S. Gov't
      5. Research Support, U.S. Gov't, P.H.S.
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/15542805/
      title
      Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease.

      Preserved source evidence · Not medical advice